
AbbVie Inc.
ABBV 286.20 (0.94%) 2.68
EV: $654.32(B)
Total Equity: $-4.54(B)
Debt/Equity: 48
Dividend/share: $6.9
Div. yield: 2.42%
P/E: 49.18
Forward P/E: 20.47
P/FCF: 26.80
P/S: 7.67
P/B: N/A
EPS: $5.8
EPS (fwd): $14.0
FCF/share: $10.7
Revenue/share: $37.3
Book value/share: $-2.6
ROIC: 3.3%
ROA: 1.7%
ROE: 140.9%
Margins: Gross | Op. | Net
73.7% | 24.1% | 15.7%
0.0%of Portfolio
My holdings
Day change
Total change
Est. EPS Growth > 5%
5Y Shares Out Change < 0% ROIC > 10% Debt/Equity < 1 Current Ratio > 1 Quick Ratio > 1 Net Margin > 10% Past Net Income CAGR > 0%
TTM Financials
Income (TTM)
Revenue$66.01(B)
Gross profit$48.67(B)
EBITDA$31.85(B)
Net income$10.34(B)
Gross margin73.7%
Operating margin24.1%
Net margin15.7%
Shares outstanding1.77(B)
Balance sheet
Total assets$147.68(B)
Current assets$37.48(B)
Total liabilities$152.22(B)
Current liabilities$43.10(B)
Cash & Short-term inv.$10.77(B)
Long-term debt$72.64(B)
Total intangibles$94.45(B)
PP&E$5.94(B)
Cash flow (TTM)
FCF$18.87(B)
CapEx$-1.22(B)
Dividends paid$-12.14(B)
Stock issued$172.00(M)
Stock repurchased$-1.51(B)
Stock-based comp.$1.02(B)
Debt issued$17.47(B)
Debt repaid$-5.30(B)
